| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. | Glia | 2010 | 1.34 |
| 2 | Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis. | Mol Cell Biol | 2012 | 1.28 |
| 3 | Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. | Antioxid Redox Signal | 2011 | 1.17 |
| 4 | Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice. | J Neuroinflammation | 2012 | 1.15 |
| 5 | α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease. | Hum Mol Genet | 2012 | 1.08 |
| 6 | Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. | Brain | 2013 | 0.91 |